
### [MONDO:0005496](http://purl.obolibrary.org/obo/MONDO_0005496)
**Label:** bile duct carcinoma

**Subclasses:** [MONDO:0014281](http://purl.obolibrary.org/obo/MONDO_0014281) (cholangiocarcinoma, susceptibility to), [MONDO:0019087](http://purl.obolibrary.org/obo/MONDO_0019087) (cholangiocarcinoma), [MONDO:0017590](http://purl.obolibrary.org/obo/MONDO_0017590) (carcinoma of the ampulla of vater), 

**Corr. equiv. classes:** [Orphanet:70567](http://www.orpha.net/ORDO/Orphanet_70567), [Orphanet:300557](http://www.orpha.net/ORDO/Orphanet_300557), [OMIM:615619](http://purl.obolibrary.org/obo/OMIM_615619), 

**Class expressions from DL-Learner:**

- [HP:0030153](http://purl.obolibrary.org/obo/HP_0030153) (Cholangiocarcinoma) and (not ([HP:0100763](http://purl.obolibrary.org/obo/HP_0100763) (Abnormality of the lymphatic system))) 66.67%
- [HP:0030153](http://purl.obolibrary.org/obo/HP_0030153) (Cholangiocarcinoma) and (not ([HP:0025032](http://purl.obolibrary.org/obo/HP_0025032) (Abnormality of digestive system physiology))) 66.67%
- [HP:0030153](http://purl.obolibrary.org/obo/HP_0030153) (Cholangiocarcinoma) and (not ([HP:0011354](http://purl.obolibrary.org/obo/HP_0011354) (Generalized abnormality of skin))) 66.67%
- [HP:0030153](http://purl.obolibrary.org/obo/HP_0030153) (Cholangiocarcinoma) and (not ([HP:0011121](http://purl.obolibrary.org/obo/HP_0011121) (Abnormality of skin morphology))) 66.67%
- [HP:0030153](http://purl.obolibrary.org/obo/HP_0030153) (Cholangiocarcinoma) and (not ([HP:0003271](http://purl.obolibrary.org/obo/HP_0003271) (Visceromegaly))) 66.67%
- [HP:0030153](http://purl.obolibrary.org/obo/HP_0030153) (Cholangiocarcinoma) and (not ([HP:0002715](http://purl.obolibrary.org/obo/HP_0002715) (Abnormality of the immune system))) 66.67%
- [HP:0030153](http://purl.obolibrary.org/obo/HP_0030153) (Cholangiocarcinoma) and (not ([HP:0001939](http://purl.obolibrary.org/obo/HP_0001939) (Abnormality of metabolism/homeostasis))) 66.67%
- [HP:0030153](http://purl.obolibrary.org/obo/HP_0030153) (Cholangiocarcinoma) and (not ([HP:0001871](http://purl.obolibrary.org/obo/HP_0001871) (Abnormality of blood and blood-forming tissues))) 66.67%
- [HP:0030153](http://purl.obolibrary.org/obo/HP_0030153) (Cholangiocarcinoma) and (not ([HP:0001574](http://purl.obolibrary.org/obo/HP_0001574) (Abnormality of the integument))) 66.67%
- [HP:0030153](http://purl.obolibrary.org/obo/HP_0030153) (Cholangiocarcinoma) and (not ([HP:0001438](http://purl.obolibrary.org/obo/HP_0001438) (Abnormality of abdomen morphology))) 66.67%
- [HP:0030153](http://purl.obolibrary.org/obo/HP_0030153) (Cholangiocarcinoma) and (not ([HP:0001396](http://purl.obolibrary.org/obo/HP_0001396) (Cholestasis))) 66.67%
- [HP:0030153](http://purl.obolibrary.org/obo/HP_0030153) (Cholangiocarcinoma) and (not ([HP:0000951](http://purl.obolibrary.org/obo/HP_0000951) (Abnormality of the skin))) 66.67%
- [HP:0100574](http://purl.obolibrary.org/obo/HP_0100574) (Biliary tract neoplasm) 60.06%
- [HP:0030153](http://purl.obolibrary.org/obo/HP_0030153) (Cholangiocarcinoma) and (not ([HP:0100279](http://purl.obolibrary.org/obo/HP_0100279) (Ulcerative colitis))) 52.02%
- [HP:0030153](http://purl.obolibrary.org/obo/HP_0030153) (Cholangiocarcinoma) and (not ([HP:0012522](http://purl.obolibrary.org/obo/HP_0012522) (Spider hemangioma))) 52.02%


